The Miami Entrepreneur

Viking Therapeutics’ stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD

Read Time:6 Second

Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post The U.S. fertility rate is falling. Is there anything we can do?
Next post Wall Street’s most bearish firm on stocks says there’s a chance of an upswing